Antithrombin III Deficiency - 11 Studies Found

Completed : Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
: Antithrombin III Deficiency
: 2005-05-10
: Biological: Recombinant human antithrombin (rhAT) Up to 24 hours prior to the scheduled elective surgica
Completed : Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
: Antithrombin III Deficiency
: 2006-04-26
: Drug: Plasma-derived AT-III concentrate Segment I: A singl
Completed : Atenativ Effect on Uterine Blood Flow and Preeclampsia
: Antithrombin III Deficiency
: 2014-10-28
: Drug: Atenativ intravenous transfusion Other Name: a
Completed : A Study of KW-3357 in Congenital Antithrombin Deficiency
: Congenital Antithrombin Deficiency
: 2009-07-10
: Drug: KW-3357 50IU/mL, IV single dose
Terminated : Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
: Thrombophilia Due to Acquired Antithrombin III Deficiency
: 2012-02-07
: Drug: Recombinant antithrombin (rhAT) Subjects will receive an intravenous bolus of 500 units of recombi
Completed : Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
:
  • Acquired Antithrombin III Deficiency
  • Coronary Artery Bypass : 2009-01-14
    : Drug: Antithrombin III Single dose of antithrombin III sufficient to achieve a preoperative level of 120
Completed : Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery
: ATIII Deficiency
: 2014-04-01
:
  • Drug: Anti-thrombin III

Completed : Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
: Antithrombin Deficiency, Congenital
: 2003-03-17
: Biological: Recombinant Human Antithrombin (rhAT) Biological/Vaccine: Recombinant human antithrombin(rhA
Not yet recruiting : Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients
: Antithrombin Deficiency Type 2
: 2017-03-21
: Drug: ATryn continuous infusion replenish serum thrombin levels
Completed : "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
:
  • Congenital Heart Diseases
  • Conotruncal Defects
  • Congenital D
    : 2015-07-13
    : Other: none intervention
Next >>>